Ranjit Singh Makar, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Makar’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$2,842
Medicare paid this office $2,842 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 71 · Health risk score 3.13. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
The office billed $19,161, Medicare allowed $3,519 and paid $2,842; for 19 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 19 | 71 | 3.13 | $19,161 | $2,842 |
| 2022 | 73 | 171 | 73 | 1.42 | $43,728 | $15,062 |
| 2021 | 158 | 411 | 72 | 1.72 | $100,097 | $37,932 |
| 2020 | 80 | 142 | 72 | 3.11 | $35,519 | $11,351 |
| 2019 | 175 | 310 | 72 | 2.69 | $74,326 | $20,459 |
| 2017 | 259 | 497 | 68 | 2.32 | $87,803 | $30,389 |
| 2016 | 379 | 952 | 67 | 2.38 | $160,117 | $59,294 |
| 2015 | 249 | 521 | 65 | 2.22 | $92,738 | $34,289 |
| 2014 | 174 | 369 | 67 | 2.07 | $63,289 | $24,268 |
| 2013 | 178 | 411 | 65 | 1.81 | $73,145 | $28,607 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 5 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $3,508 | $175 |
| Short return visit (20+ min) | 29 | $2,409 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,963 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,517 | $58 |
| New patient visit (30+ min) | 19 | $1,377 | $72 |
2021: 7 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $6,033 | $110 |
| Short return visit (20+ min) | 53 | $5,194 | $68 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,066 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,608 | $58 |
| New patient visit (30+ min) | 53 | $4,237 | $80 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,441 | $87 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,178 | $91 |
2020: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $4,238 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,944 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,019 | $85 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 134 | $13,001 | $58 |
| Hospital discharge day management, more than 30 minutes | 27 | $2,312 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,075 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,908 | $83 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $9,229 | $53 |
| Return visit (30+ min) | 53 | $5,193 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,513 | $98 |
| Initial hospital observation care per day, typically 50 minutes | 43 | $4,455 | $101 |
| Hospital discharge day management, 30 minutes or less | 33 | $1,781 | $52 |
| Short return visit (20+ min) | 28 | $1,386 | $45 |
| New patient visit (45+ min) | 13 | $1,349 | $104 |
| Follow-up observation care per day, typically 25 minutes | 17 | $1,135 | $54 |
| Hospital observation care on day of discharge | 12 | $652 | $54 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 157 | $22,044 | $55 |
| Initial hospital observation care per day, typically 50 minutes | 92 | $9,537 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 70 | $7,254 | $102 |
| Return visit (30+ min) | 53 | $6,516 | $70 |
| Follow-up observation care per day, typically 25 minutes | 55 | $4,472 | $56 |
| Hospital discharge day management, 30 minutes or less | 61 | $3,452 | $56 |
| Short return visit (20+ min) | 36 | $1,908 | $50 |
| Hospital observation care on day of discharge | 28 | $1,667 | $56 |
2015: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $9,624 | $55 |
| Return visit (30+ min) | 57 | $6,495 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,562 | $101 |
| Initial hospital observation care per day, typically 50 minutes | 34 | $3,773 | $102 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,044 | $55 |
| Short return visit (20+ min) | 30 | $1,609 | $47 |
| Follow-up observation care per day, typically 25 minutes | 18 | $1,246 | $57 |
| Hospital observation care on day of discharge | 18 | $1,020 | $57 |
2014: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $7,059 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,774 | $111 |
| Short return visit (20+ min) | 32 | $2,782 | $55 |
| Initial hospital observation care per day, typically 50 minutes | 23 | $2,290 | $95 |
| Return visit (30+ min) | 22 | $1,772 | $68 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,399 | $58 |
| Hospital observation care on day of discharge | 11 | $642 | $58 |
2013: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $5,329 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,711 | $107 |
| Return visit (30+ min) | 31 | $4,136 | $81 |
| Initial hospital observation care per day, typically 50 minutes | 33 | $3,512 | $106 |
| Hospital discharge day management, 30 minutes or less | 39 | $2,291 | $57 |
| Short return visit (20+ min) | 19 | $1,852 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,720 | $78 |
Medicaid work
$2,772 in 2022
Medicaid paid $2,772 for 55 billed services this clinician did in 2022, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 55 | $2,772 |
| 2022 | 55 | 1 | 18 | $2,772 |
| 2021 | 302 | 4 | 21 | $20,141 |
| 2020 | 39 | 2 | 19 | $2,092 |
| 2019 | 623 | 1 | 27 | $5,045 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 132 | $7,980 |
| New patient visit (30+ min) | 109 | $7,338 |
| Upper gastrointestinal endoscopy with biopsy | 48 | $4,280 |
| Short return visit | 13 | $544 |
2020
| New patient visit (30+ min) | 25 | $1,538 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 14 | $554 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 623 | $5,045 |
Drugs they prescribed that Part D paid
$9,737
Pharmacies billed $9,737 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 280) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
264 generic and 16 brand-name prescriptions · $9,737 in drug cost · 48 antibiotic prescriptions to 36 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gavilyte-C | 99 | $2,217 | $22 |
| Pantoprazole | 83 | $711 | $9 |
| Ciprofloxacin | 30 | $212 | $7 |
| Omeprazole | 12 | $113 | $9 |
Year by year
| 2024 | 280 | 187 | 0% (0) | 6% | $9,737 |
| 2023 | 133 | 73 | 0% (0) | None | $4,305 |
| 2022 | 179 | 69 | 0% (0) | 20% | $45,748 |
| 2021 | 247 | 114 | 0% (0) | 21% | $33,140 |
| 2020 | 42 | 23 | 0% (0) | None | $6,332 |
| 2019 | 19 | None | 0% (0) | None | $745 |
| 2018 | 300 | 64 | 0% (0) | None | $9,878 |
| 2017 | 1,676 | 122 | 2% (38) | 14% | $90,406 |
| 2016 | 1,841 | 125 | 3% (49) | 14% | $93,709 |
| 2015 | 1,252 | 115 | 2% (29) | None | $47,121 |
| 2014 | 780 | 83 | 2% (17) | None | $26,459 |
| 2013 | 556 | 77 | 6% (31) | None | $25,982 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Gavilyte-C | 27 | $628 | $23 |
| Omeprazole | 12 | $209 | $17 |
| Pantoprazole | 19 | $207 | $11 |
2022: 3 drugs
| Pantoprazole | 53 | $1,025 | $19 |
| Omeprazole | 20 | $244 | $12 |
| Propranolol | 12 | $142 | $12 |
2021: 5 drugs
| Pantoprazole | 70 | $2,150 | $31 |
| Plenvu | 15 | $1,933 | $129 |
| Suprep | 17 | $1,864 | $110 |
| Omeprazole | 50 | $1,027 | $21 |
| Lactulose | 15 | $497 | $33 |
2020: 1 drug
| Pantoprazole | 12 | $135 | $11 |
2018: 9 drugs
| Metoprolol | 13 | $833 | $64 |
| Levothyroxine | 15 | $298 | $20 |
| Valsartan-Hydrochlorothiazide | 13 | $188 | $14 |
| Amlodipine Besylate | 19 | $185 | $10 |
| Pantoprazole | 15 | $178 | $12 |
| Simvastatin | 22 | $119 | $5 |
| Metformin | 17 | $110 | $6 |
| Montelukast | 11 | $85 | $8 |
| Lisinopril | 17 | $73 | $4 |
2017: 47 drugs
| Novolog Flexpen | 24 | $12,628 | $526 |
| Novolog Mix 70-30 Flexpen | 14 | $10,518 | $751 |
| Lantus Solostar | 19 | $7,026 | $370 |
| Eliquis | 12 | $4,705 | $392 |
| Lantus | 14 | $4,526 | $323 |
| Metoprolol | 51 | $1,677 | $33 |
| Clobetasol Propionate | 13 | $1,664 | $128 |
| Levothyroxine | 62 | $1,266 | $20 |
| Ventolin Hfa | 12 | $1,213 | $101 |
| Tamsulosin | 51 | $987 | $19 |
| Atorvastatin | 56 | $911 | $16 |
| Ultra-Fine Mini Pen Needle | 14 | $745 | $53 |
| Fenofibrate | 25 | $716 | $29 |
| Esomeprazole Magnesium | 12 | $568 | $47 |
| Omeprazole | 66 | $536 | $8 |
| Fenofibrate | 19 | $481 | $25 |
| Amlodipine Besylate | 85 | $466 | $5 |
| Lisinopril | 91 | $436 | $5 |
| Simvastatin | 93 | $423 | $5 |
| Amiloride | 11 | $394 | $36 |
| Metoprolol | 65 | $389 | $6 |
| Allopurinol | 19 | $343 | $18 |
| Gabapentin | 26 | $340 | $13 |
| Calcitriol | 12 | $330 | $27 |
| Pantoprazole | 33 | $325 | $10 |
| Metformin | 68 | $324 | $5 |
| Amlodipine Besylate-Benazepril | 14 | $312 | $22 |
| Pravastatin | 11 | $309 | $28 |
| Valsartan-Hydrochlorothiazide | 23 | $299 | $13 |
| Potassium Chloride | 12 | $287 | $24 |
| Spironolactone | 20 | $283 | $14 |
| Hydrochlorothiazide | 57 | $240 | $4 |
| Hydralazine | 20 | $232 | $12 |
| Bisoprolol | 14 | $185 | $13 |
| Losartan | 22 | $182 | $8 |
| Alendronate | 16 | $171 | $11 |
| Montelukast | 16 | $160 | $10 |
| Warfarin | 13 | $157 | $12 |
| Carvedilol | 16 | $142 | $9 |
| Ropinirole | 12 | $131 | $11 |
| Tramadol | 17 | $121 | $7 |
| Insulin | 12 | $105 | $9 |
| Glipizide | 32 | $95 | $3 |
| Atenolol | 12 | $58 | $5 |
| Paroxetine | 11 | $56 | $5 |
| Furosemide | 18 | $45 | $3 |
| Lisinopril-Hydrochlorothiazide | 11 | $34 | $3 |
2016: 48 drugs
| Lantus | 11 | $6,815 | $620 |
| Zetia | 18 | $5,073 | $282 |
| Metoprolol | 48 | $1,828 | $38 |
| Ventolin Hfa | 19 | $1,137 | $60 |
| Levothyroxine | 66 | $1,072 | $16 |
| Esomeprazole Magnesium | 11 | $968 | $88 |
| Fenofibrate | 25 | $966 | $39 |
| Omeprazole | 97 | $912 | $9 |
| Tamsulosin | 48 | $888 | $19 |
| Hydrocodone-Acetaminophen | 16 | $725 | $45 |
| Gabapentin | 45 | $643 | $14 |
| Enalapril Maleate | 12 | $631 | $53 |
| Lisinopril | 105 | $626 | $6 |
| Atorvastatin | 50 | $584 | $12 |
| Fenofibrate | 16 | $552 | $34 |
| Amlodipine Besylate | 106 | $509 | $5 |
| Simvastatin | 66 | $394 | $6 |
| Potassium Chloride | 20 | $379 | $19 |
| Hydrochlorothiazide | 82 | $378 | $5 |
| Doxazosin Mesylate | 16 | $377 | $24 |
| Metformin | 61 | $372 | $6 |
| Cartia Xt | 12 | $344 | $29 |
| Hydralazine | 25 | $331 | $13 |
| Minoxidil | 13 | $331 | $25 |
| Allopurinol | 22 | $314 | $14 |
| Amlodipine Besylate-Benazepril | 13 | $301 | $23 |
| Diclofenac | 11 | $294 | $27 |
| Metoprolol | 44 | $287 | $7 |
| Spironolactone | 22 | $279 | $13 |
| Carvedilol | 35 | $211 | $6 |
| Atenolol-Chlorthalidone | 11 | $192 | $17 |
| Clopidogrel | 15 | $175 | $12 |
| Pantoprazole | 19 | $171 | $9 |
| Losartan | 25 | $166 | $7 |
| Fluticasone Propionate | 14 | $163 | $12 |
| Tramadol | 26 | $154 | $6 |
| Bisoprolol | 13 | $150 | $12 |
| Glipizide | 26 | $137 | $5 |
| Furosemide | 33 | $134 | $4 |
| Clonazepam | 15 | $116 | $8 |
| Torsemide | 12 | $116 | $10 |
| Warfarin | 14 | $113 | $8 |
| Sertraline | 13 | $110 | $8 |
| Lisinopril-Hydrochlorothiazide | 22 | $101 | $5 |
| Alprazolam | 15 | $61 | $4 |
| Atenolol | 14 | $56 | $4 |
| Paroxetine | 11 | $50 | $5 |
| Trazodone | 11 | $44 | $4 |
2015: 25 drugs
| Metoprolol | 34 | $1,151 | $34 |
| Proair Hfa | 13 | $825 | $63 |
| Omeprazole | 83 | $667 | $8 |
| Gabapentin | 55 | $638 | $12 |
| Doxazosin Mesylate | 16 | $537 | $34 |
| Fenofibrate | 12 | $534 | $45 |
| Amlodipine Besylate | 107 | $484 | $5 |
| Atorvastatin | 40 | $474 | $12 |
| Levothyroxine | 42 | $418 | $10 |
| Potassium Chloride | 27 | $410 | $15 |
| Lisinopril | 78 | $400 | $5 |
| Tamsulosin | 18 | $369 | $21 |
| Fluticasone Propionate | 23 | $306 | $13 |
| Metformin | 38 | $284 | $7 |
| Carvedilol | 49 | $274 | $6 |
| Simvastatin | 47 | $242 | $5 |
| Metoprolol | 32 | $186 | $6 |
| Hydrochlorothiazide | 44 | $173 | $4 |
| Hydrocodone-Acetaminophen | 12 | $140 | $12 |
| Clopidogrel | 11 | $121 | $11 |
| Furosemide | 24 | $112 | $5 |
| Pantoprazole | 12 | $111 | $9 |
| Spironolactone | 11 | $97 | $9 |
| Glipizide | 18 | $93 | $5 |
| Warfarin | 12 | $80 | $7 |
2014: 19 drugs
| Spiriva | 13 | $3,910 | $301 |
| Proair Hfa | 31 | $1,859 | $60 |
| Metoprolol | 16 | $481 | $30 |
| Omeprazole | 36 | $383 | $11 |
| Atorvastatin | 23 | $352 | $15 |
| Fluoxetine | 13 | $324 | $25 |
| Amlodipine Besylate | 61 | $315 | $5 |
| Gabapentin | 32 | $309 | $10 |
| Lisinopril | 47 | $306 | $7 |
| Fluticasone Propionate | 20 | $304 | $15 |
| Simvastatin | 40 | $283 | $7 |
| Levothyroxine | 32 | $235 | $7 |
| Carvedilol | 37 | $214 | $6 |
| Pantoprazole | 21 | $194 | $9 |
| Glipizide | 22 | $128 | $6 |
| Hydrochlorothiazide | 27 | $103 | $4 |
| Metformin Hcl Er | 12 | $83 | $7 |
| Metformin | 14 | $82 | $6 |
| Allopurinol | 12 | $44 | $4 |
2013: 12 drugs
| Metoprolol | 15 | $555 | $37 |
| Omeprazole | 29 | $535 | $18 |
| Hydrocodone-Acetaminophen | 23 | $450 | $20 |
| Lisinopril | 43 | $295 | $7 |
| Amlodipine Besylate | 41 | $254 | $6 |
| Finasteride | 11 | $210 | $19 |
| Carvedilol | 14 | $173 | $12 |
| Losartan | 11 | $157 | $14 |
| Simvastatin | 14 | $146 | $10 |
| Gabapentin | 14 | $131 | $9 |
| Metformin | 11 | $90 | $8 |
| Hydrochlorothiazide | 12 | $55 | $5 |
Money from drug and device companies
$87 in 2024
| 2024 | 1 | 2 | None | $87 |
| 2023 | 3 | 4 | None | $1,038 |
| 2022 | 3 | 12 | None | $227 |
| 2021 | 13 | 78 | None | $1,105 |
| 2020 | 5 | 13 | None | $1,036 |
| 2019 | 5 | 19 | None | $2,610 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Exalt Model D | $87 | 2 payments
|
See all 2 published payments
| Boston Scientific | Meals · 2024-03-07 | Exalt Model D | $38 |
| Boston Scientific | Meals · 2024-03-06 | Exalt Model D | $49 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $1,038
| Ovesco Endoscopy USA | None | $858 | 1 payment
|
| Boston Scientific | Exalt Model D | $138 | 1 payment
|
| Abbvie | Rinvoq | $43 | 2 payments
|
2022: $227
| Abbvie | Humira | $126 | 6 payments
|
| Janssen Biotech | Stelara | $71 | 5 payments
|
| Gilead Sciences | None | $30 | 1 payment
|
2021: $1,105
| Janssen Biotech | Stelara | $245 | 27 payments
|
| AbbVie | Humira | $207 | 15 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $156 | 14 payments
|
| Nestle HealthCare Nutrition | Zenpep | $130 | 1 payment
|
| Gilead Sciences | None | $98 | 4 payments
|
| QOL Medical | Sucraid | $72 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $62 | 4 payments
|
| Intra-Sana Laboratories | Reltone 200 Mg | $42 | 1 payment
|
| Ferring Pharmaceuticals | Cimzia | $30 | 2 payments
|
| Ironwood Pharmaceuticals | Linzess | $17 | 1 payment
|
| Braintree Laboratories | Suprep Bowel Prep | $16 | 1 payment
|
| RedHill Biopharma | Talicia | $16 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $14 | 1 payment
|
2020: $1,036
| Boston Scientific | Spyglass | $925 | 8 payments
|
| Gilead Sciences | None | $57 | 2 payments
|
| RedHill Biopharma | Movantik | $24 | 1 payment
|
| Ferring Pharmaceuticals | Cimzia | $17 | 1 payment
|
| Janssen Biotech | Stelara | $12 | 1 payment
|
2019: $2,610
| Boston Scientific | General Therapies | $2,166 | 12 payments
|
| Cook Medical | Cook Medical Biliary | $295 | 3 payments
|
| FUJIFILM Wako Diagnostics U.S.A. | Wako Hcc Biomarker(S) Dcp and Afp-L3 | $101 | 1 payment
|
| Eisai | Lenvima | $33 | 2 payments
|
| AbbVie | Mavyret | $16 | 1 payment
|
Professional record
- NPI
- 1083858997
- Licence
- NV 14317
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NV 1184601239
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 270 International Cir Fl 2, San Jose, CA, 95119
- NPI first listed
- 2009-04-22
- NPI last updated
- 2026-06-17
- NPI record certified
- 2026-06-17
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.